Subpart C - LABELING

Section 341.70 - Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product)
Section 341.72 - Labeling of antihistamine drug products
Section 341.74 - Labeling of antitussive drug products
Section 341.76 - Labeling of bronchodilator drug products
Section 341.78 - Labeling of expectorant drug products
Section 341.80 - Labeling of nasal decongestant drug products
Section 341.85 - Labeling of permitted combinations of active ingredients
Section 341.90 - Professional labeling